Biogen Inc
(NASDAQ:BIIB)
Reata Pharmaceuticals (RETA) was acquired by Biogen (BIIB) on Tuesday, September 26, 2023 for $7.3B paid in cash
$257.52
-0.53[-0.21%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$257.52
0[0.00%]
Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ:BIIB), Quotes and News Summary

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open258.440Close257.520
Vol / Avg.806.443K / 1.004MMkt Cap37.295B
Day Range255.160 - 261.37552 Wk Range194.690 - 334.580
Globe Newswire - Sep 6, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS4.000

(EXPECTED) 2023-10-24

REV2.390B
Q2 2023Est.ActualSurprise
EPS3.7704.020 0.2500
REV2.370B2.456B86.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-09-06HSBCMorten HerholdtInitiates Coverage OnBuyAnnounces-360.00
2023-09-05Morgan StanleyMatthew HarrisonMaintainsOverweightOverweightRaises363.00381.00
2023-08-29RBC CapitalBrian AbrahamsMaintainsOutperformOutperformRaises354.00357.00
2023-08-14MizuhoSalim SyedMaintainsBuyBuyLowers340.00335.00

Related Companies

TickerCompanyChg %Mkt Cap
BIIBBiogen-0.21%37.3B
LEGNLegend Biotech5.66%12.4B
EXASExact Sciences1.55%12.2B
SRPTSarepta Therapeutics3.37%11.5B
NBIXNeurocrine Biosciences0.7%11.3B
Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ: BIIB) was reported by HSBC on Wednesday, September 6, 2023. The analyst firm set a price target for 360.00 expecting BIIB to rise to within 12 months (a possible 39.79% upside). 87 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $257.52 last updated September 27, 2023 at 8:00 PM UTC.

Q

Does Biogen (BIIB) pay a dividend?

A

There is no dividend information for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen’s Q3 earnings are confirmed for Tuesday, October 24, 2023.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.